Zest Health, a pioneering virtual care company specializing in treating patients with inflammatory skin diseases, has recently secured $14 million in seeding funding. This significant investment round was spearheaded by Roivant Health, a prominent player in the healthcare industry that not only incubated Zest Health but also actively participated in the funding.
What sets Zest Health apart is its innovative approach to patient care. Through its user-friendly virtual platform, patients can access individualized and reactive care that is tailored to their specific needs. By leveraging patient data, Zest Health is able to craft personalized treatment regimens that may include prescription medications, over-the-counter remedies, lifestyle modifications, and preventive interventions. The ultimate goal is to offer patients with inflammatory skin conditions, such as eczema and psoriasis, a more convenient and long-lasting relief from their symptoms.
In a statement, Zest Health highlighted the overreliance on expensive biologic medications among patients with skin diseases and emphasized the need for more accessible and sustainable treatment options. With the newly acquired funding, Zest Health plans to expand its partnerships with health plans and employers, further solidifying its presence in the virtual care landscape.
Olivia Deitcher, CEO of Zest Health and a psoriasis patient herself, shared her personal experience with the limitations of traditional dermatology care. She emphasized Zest Health’s commitment to providing expert support to patients both during and between flares, without solely relying on biologics. This patient-centric approach has resonated with many individuals seeking comprehensive and effective solutions for their inflammatory skin conditions.
In the competitive market of virtual care for skin diseases, Zest Health faces formidable competitors such as Dario Health, Sidekick Health, and Zerigo Health. Each of these companies offers unique digital solutions aimed at improving patient outcomes and enhancing treatment adherence. With Zest Health’s focus on personalized care and radical access to expert dermatology services, the company is well-positioned to make a significant impact in the virtual care space for inflammatory skin diseases.
As Zest Health continues to innovate and expand its reach, patients can look forward to a future where managing inflammatory skin conditions becomes more manageable and effective. Through its commitment to providing personalized care and lasting relief, Zest Health is poised to revolutionize the way patients with skin diseases receive treatment and support.
